Interleukin-6 polymorphism: A genetic risk factor for cardiac transplant related coronary vasculopathy?

Journal of Heart and Lung Transplantation

Volumn 24, Issue 5, 2005, Pages 559-565

  Densem, Cameron G ^a,c   Ray, Michele ^b   Hutchinson, Ian V ^b   Yonan, Nizar ^a   Brooks, Nicholas H ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; GENE SEQUENCE; GENETIC RISK; GENOTYPE; HEART GRAFT; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; CORONARY ARTERIOSCLEROSIS; GENETIC PREDISPOSITION TO DISEASE; HEART TRANSPLANTATION; HUMANS; INTERLEUKIN-6; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 18844401943     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.03.016     Document Type: Article

References (67)

1. M.E. Billingham Cardiac transplant arteriosclerosis Transplant Proc 19 suppl 5 1987 19 25
2. D.E. Johnson, S.Z. Gao, J.S. Schroeder, W.M. DeCampi, M.E. Billingham The spectrum of coronary artery pathologic findings in human cardiac allografts J Heart Lung Transplant 8 1989 349 359
3. R.L. Benza, H.E. Grenett, R.C. Bourge Gene polymorphisms for Plasminogen Activator Inhibitor-1/Tissue Plasminogen Activator and development of allograft coronary artery disease Circulation 98 1998 2248 2254
4. C.G. Densem, I.V. Hutchinson, A. Cooper, N. Yonan, N.H. Brooks Polymorphism of the Transforming Growth Factor-Beta 1 gene correlates with the development of Coronary Vasculopathy following Cardiac Transplantation J Heart Lung Transplant 19 2000 551 556
5. D.A. Cunningham, S.J. Crisp, M. Barbir, F. Lazem, M.J. Dunn, M.H. Yacoub Donor ACE gene polymorphism a genetic risk factor for accelerated coronary sclerosis following cardiac transplantation Eur Heart J 19 1998 319 325
6. E.T. Keller, J.T. Wanagat, W.B. Erschler Molecular and cellular biology of interleukin-6 and its receptor Frontiers in Bioscience 1 1996 340 357
7. F.J. Neumann, I. Ott, M. Gawaz Cardiac release of cytokines and inflammatory responses in acute myocardial infarction Circulation 92 1995 748 755
8. A. Kharazmi, H. Nielsen, C. Rechnitzer, K. Bendtzen Interleukin 6 primes human neutrophil and monocyte oxidative burst response Immunol Lett 21 1989 177 184
9. A. Mantovani, F. Bussolino, E. Dejana Cytokine regulation of endothelial cell function FASEB J 6 1992 2591 2599
10. H. Lou, T. Kodama, Y.N. Wang, N. Katz, P. Ramwell, M.L. Foegh L-arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to Insulin-like Growth Factor-1 and Interleukin-6 J Heart Lung Transplant 15 1996 1248 1257
11. U. Ikeda, M. Ikeda, Y. Seino, M. Takahashi, S. Kano, K. Shimada Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits Atherosclerosis 92 1992 213 218
12. L. Yuan, S. Inoue, Y. Saito, O. Nakajima An evaluation of the effects of cytokines on intracellular oxidative production in normal neutrophils by flow cytometry Exp Cell Res 209 1993 375 381
13. M.P. Bevilacqua, S. Stengelin, M.A. Gimbrone Jr, B. Seed Endothelial leukocyte adhesion molecule 1 an inducible receptor for neutrophils related to complement regulatory proteins and lectins Science 243 1989 1160 1165
14. U. Ikeda, M. Ikeda, Y. Seino Expression of intracellular adhesion molecule 1 in rat vascular smooth muscle cells by pro-inflammatory cytokines Atherosclerosis 104 1993 61 68
15. N. Mauro, I. Morita, M. Shirao, S.I. Murota IL-6 increases endothelial permeability in vitro Endocrinology 131 1992 710 714
16. D.A. Sukovich, K. Kauser, F.D. Shirley, V. DelVecchio, M. Halks-Miller, G.M. Rubanyi Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice inhibition by 17beta-estradiol Arterioscler Thromb Vasc Biol 18 1998 1498 1505
17. Z. Szekanecz, M.R. Shah, W.H. Pearce, A.E. Koch Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4 the possible role for IL-6 and interferon-gamma in vascular inflammation Agents Actions 42 1994 159 162
18. H.G. Rus, R. Vlaicu, F. Niculescu Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall Atherosclerosis 127 1996 263 271
19. Y. Seino, U. Ikeda, M. Ikeda Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions Cytokine 6 1994 87 91
20. S.A. Huber, P. Sakkinen, D. Conze, N. Hardin, R. Tracy Interleukin-6 exacerbates early atherosclerosis in mice Arterioscler Thromb Vasc Biol 19 1999 2364 2367
21. P.M. Ridker, N. Rifai, M.J. Stampfer, C.H. Hennekens Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 2000 1767 1772
22. A.D. Simon, S. Yazdani, W. Wang, A. Schwartz, L.E. Rabbani Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina J Thromb Thrombolysis 9 2000 217 222
23. I. Ikonomidis, F. Andreotti, E. Economou, C. Stefanadis, P. Toutouzas, P. Nihoyannopoulos Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin Circulation 100 1999 793 798
24. A. Mazzone, S. De Servi, M. Vezzoli Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease Atherosclerosis 145 1999 369 374
25. S. Yazdani, A.D. Simon, R. Vidhun, C. Gulotta, A. Schwartz, L.E. Rabbani Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions Am Heart J 136 1998 357 361
26. M. Erren, H. Reinecke, R. Junker Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries Arterioscler Thromb Vasc Biol 19 1999 2355 2363
27. Y. Furukawa, A. Matsumori, M.W. Hwang Cytokine gene expression during the development of graft coronary artery disease in mice Jpn Circ J 63 1999 775 782
28. A. Fyfe, P. Daly, L. Galligan, L. Pirc, C. Feindel, C. Cardella Coronary sinus sampling of cytokines after heart transplantation evidence for macrophage activation and interleukin-4 production within the graft J Am Coll Cardiol 21 1993 171 176
29. C.C. Baan, C.T.J. Holweg, H.G.M. Niesters Intragraft cytokine and growth factor mRNA expression in relation to graft vascular disease after heart transplantation Transplant Proc 29 1997 2535 2536
30. M. Weis, S.M. Wildhirt, C. Schulze Modulation of coronary vasomotor tone by cytokines in cardiac transplant recipients Transplantation 68 1999 1263 1267
31. L. Gullestad, S. Simonsen, T. Ueland Possible role of proinflammatory cytokines in heart allograft coronary artery disease Am J Cardiol 84 1999 999 1003
32. D. Fishman, G. Faulds, R. Jeffery The Effect of Novel Polymorphisms in the Interleukin-6 (IL-6) Gene on IL-6 Transcription and Plasma IL-6 Levels, and an Association with Systemic-Onset Juvenile Chronic Arthritis J Clin Invest 102 1998 1369 1376
33. S.E. Humphries, L.A. Luong, M.S. Ogg, E. Hawe, G.J. Miller The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men Eur Heart J 22 2001 2243 3352
34. T. Hirano Interleukin-6 and its relation to inflammation and disease Clin Immunol and Immunopathol 62 1992 S60 S65
35. J. Bauer, F. Herrmen Interleukin-6 in clinical medicine Ann Hematol 62 1991 203 210
36. T. Hirano IL-6 and Its Relation to Inflammation and Disease Clini Immunol and Immunopathol 62 1992 60 65
37. T. Hirano The Biology of IL-6 Chem Immunology 51 1992 153 180
38. K. Pethig, B. Heublein, I. Kutschka, A. Haverich Systemic inflammatory response in cardiac allograft vasculopathy high-sensitive C-reactive protein is associated with progressive luminal obstruction Circulation 102 Suppl 3 2000 III233 III236
39. S.J. van Deventer, H.R. Buller, J.W. ten Cate, L.A. Aarden, C.E. Hack, A. Sturk Experimental endotoxaemia in humans analysis of cytokine release and coagulation, fibrinolytic, and complement pathways Blood 76 1990 2520 2526
40. D.G. Hesse, K.J. Tracey, Y. Fong Cytokine appearance in human endotoxaemia and primate bacteremia Surg Gynecol Obstet 166 1988 147 153
41. R. Schindler, J. Mancilla, S. Endres, R. Ghorbani, S.C. Clark, C.A. Dinarello Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells IL-6 suppresses IL-1 and TNF Blood 75 1990 40 47
42. P.C. Heinrich, J.V. Castell, T. Andus Interleukin-6 and the acute phase response Biochem J 265 1990 621 636
43. K. Lyson, S.M. McCann The effect of interleukin-6 on pituitary hormone release in vivo and in vitro Neuroendocrinology 54 1991 262 266
44. J.M. Fernandez-Real, M. Broch, J. Vendrell, C. Richart, W. Ricart Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects J Clin Endocrinol Metab 85 2000 1334 1339
45. R. Rauramaa, S.B. Vaisanen, L.A. Luong Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis Arterioscler Thromb Vasc Biol 20 2000 2657 2662
46. C.F. Terry, V. Loukaci, F.R. Green Co-operative influence of genetic polymorphisms on interleukin-6 transcriptional regulation J Biol Chem 275 2000 18138 18144
47. Y. Naitoh, J. Fukata, T. Tominaga Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats Biochem Biophys Res Commun 155 1988 1459 1463
48. C. Tsigos, D.A. Papanicolaou, R. Defensor, C.S. Mitsiadis, I. Kyrou, G.P. Chrousos Dose-effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure Neuroendocrinology 66 1997 54 62
49. J. Fukata, T. Usui, Y. Naitoh, Y. Nakai, H. Imura Effects of recombinant human interleukin-1 alpha, -1 beta, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumour cell line AtT-20 J Endocrinol 122 1989 33 39
50. D.A. Papanicolaou, J.S. Petrides, C. Tsigos Exercise stimulates interleukin-6 secretion inhibition by glucocorticoids and correlation with catecholamines Am J Physiol 217 1996 E601 E605
51. S. Wan, A. Marchant, J.M. DeSmet Human cytokine responses to cardiac transplantation and coronary artery bypass grafting J Thorac Cardiovasc Surg 111 1996 469 477
52. J.E. Garcia, A.M. Lopez, M.R. de Cabo Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level Mediators Inflamm 8 1999 253 259
53. G.E. Saris, K.E. Moore, J.S. Schroeder Cardiac transplantation the Stanford experience in the cyclosporine era J Thorac Cardiovasc Surg 108 1994 240 252
54. L.D. Scharples, N. Caine, P. Mullins Risk Factor analysis for the major hazards following heart transplantation-rejection, infection, and coronary occlusive disease Transplantation 52 1991 244 252
55. S.Z. Gao, S.A. Hunt, J.S. Schroeder, E.L. Alderman, I.R. Hill, E.B. Stinson Early development of accelerated graft coronary artery disease risk factors and course J Am Coll Cardiol 28 1996 673 679
56. P.K. Koskinen, M.S. Nieminen, L.A. Krogerus Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts J Heart Lung Transplant 12 1993 724 729
57. L.D. Sharples, C.H. Jackson, J. Parameshwar, J. Wallwork, S.R. Large Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy Transplantation 76 2003 679 682
58. R.S. Fujinami, J.A. Nelson, L. Walker, M.B. Oldstone Sequence homology and immunologic cross reactivity of human cytomegalovirus with human leukocyte antigen DR Beta chain a means for graft rejection and immunosuppression J Virol 62 1988 100 105
59. T.C. Wu, R.H. Hruban, R.F. Ambinder Demonstration of cytomegalovirus nucleic acids in the coronaries of transplanted hearts Am J Pathol 140 1992 739 747
60. P.K. Koskinen, E.A. Kallio, J.M. Tikkanen, R.K. Sihvola, P.J. Hayry, K.B. Lemstrom Cytomegalovirus infection and cardiac allograft vasculopathy Transpl Infect Dis 1 1999 115 126
61. S. Fateh-Moghadam, W. Bocksch, R. Wessely, G. Jager, R. Hetzer, M. Gawaz Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy Transplantation 76 2003 1470 1474
62. E. Seir, R. Modali, E.S. Huang Potential role of human cytomegalovirus and p53 interaction in coronary restenosis Science 165 1994 391 394
63. W.J. Waldman, P.W. Adams, C.G. Orosz T Lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells Transplantation 54 1992 887 896
64. E.A. Rose, P. Pepino, M.L. Barr Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients J Heart Lung Transplant 11 1992 S120 S123
65. D. Rott, J. Zhu, Y.F. Zhou, M.S. Burnett, A. Zalles-Ganley, S.E. Epstein IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells a new mechanistic paradigm for infection-induced atherogenesis Atherosclerosis 170 2003 223 228
66. J.J. Bouwman, F.L. Visseren, M.C. Bosch, K.P. Bouter, R.J. Diepersloot Procoagulant and inflammatory response of virus-infected monocytes Eur J Clin Invest 32 2002 759 766
67. C.Y. Tong, A. Bakran, H. Williams, L.E. Cuevas, J.S. Peiris, C.A. Hart Association of tumour necrosis factor alpha and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantation J Med Virol 64 2001 29 34